Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF‐ Mutated Anaplastic Thyroid Cancer. This evidence concerns the gene BRAF and thyroid gland undifferentiated (anaplastic) carcinoma.